JCIC Asset Management’s AbbVie ABBV Stock Holding History

JCIC Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$27.4K	Hold	131	–	–	0.01%	86
2024 Q4	$23.3K	Hold	131	–	–	0.01%	78
2024 Q3	$25.9K	Hold	131	–	–	0.01%	78
2024 Q2	$22.5K	Hold	131	–	–	0.01%	81
2024 Q1	$23.9K	Hold	131	–	–	0.01%	84
2023 Q4	$20.3K	Hold	131	–	–	0.01%	87
2023 Q3	$19.5K	Hold	131	–	–	0.01%	88
2023 Q2	$17.6K	Hold	131	–	–	0.01%	95
2023 Q1	$20.9K	Hold	131	–	–	0.01%	86
2022 Q4	$21K	Hold	131	–	–	0.01%	89
2022 Q3	$19K	Hold	131	–	–	0.01%	91
2022 Q2	$20K	Hold	131	–	–	0.01%	81
2022 Q1	$21K	Hold	131	–	–	0.01%	98
2021 Q4	$18K	Hold	131	–	–	0.01%	98
2021 Q3	$14K	Hold	131	–	–	﹤0.01%	95
2021 Q2	$18K	Hold	131	–	–	﹤0.01%	97
2021 Q1	$14K	Hold	131	–	–	﹤0.01%	97
2020 Q4	$14K	Hold	131	–	–	0.01%	92
2020 Q3	$11K	Hold	131	–	–	0.01%	89
2020 Q2	$13K	Hold	131	–	–	0.01%	81
2020 Q1	$10K	Sell	131 -60	-31%	-$5.11K	0.01%	81
2019 Q4	$17K	Hold	191	–	–	0.01%	87
2019 Q3	$14K	Hold	191	–	–	0.01%	85
2019 Q2	$14K	Hold	191	–	–	0.01%	84
2019 Q1	$15K	Hold	191	–	–	0.01%	88
2018 Q4	$18K	Hold	191	–	–	0.01%	76
2018 Q3	$18K	Hold	191	–	–	0.01%	81
2018 Q2	$18K	Buy	191 +131	+218%	+$12.8K	0.01%	68
2018 Q1	$6K	Buy	+60	New	+$6.59K	﹤0.01%	78

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JCIC Asset Management's ABBV Position: Q1 2025 in Review

JCIC Asset Management held its AbbVie (ABBV) position steady in Q1 2025 at 131 shares worth $27.4K. The position accounts for 0.01% of the portfolio, ranked #86.

JCIC Asset Management first reported a position in ABBV in Q1 2018 and has held it in 29 quarters since. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

JCIC Asset Management held 131 shares of AbbVie worth $27.4K as of Q1 2025.
JCIC Asset Management left its AbbVie share count unchanged in Q1 2025.
AbbVie made up 0.01% of JCIC Asset Management's portfolio in Q1 2025, its #86 holding.
JCIC Asset Management first reported a position in AbbVie in Q1 2018 and has held it in 29 quarters since.
3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on JCIC Asset Management's 13F filing for Q1 2025, filed 23 Apr 2025.